Principal investigator2nd budget source (all running projects)
EU HORIZON 2020
EU JA
NIH/NCI
Research Councils
The Netherlands
Principal investigatorOther external funding
Co-investigator2nd budget source
Co-investigatorOther external funding
• EU-TOPIA: Towards improved screening for breast, cervical and colorectal cancer in all of Europe (Coordinator)
• EU-SCREEN: Implementation of optimized childhood vision and hearing screening programmes in middle-income countries in Europe (Substitute coordinator)
• CANCON – European Guide on Quality Improvement in Comprehensive Cancer Control
• CISNET – Comparative Modelling of Lung Cancer Prevention and Control Policies (2005-2020)
• CISNET - Modelling to Improve Prostate Cancer Outcomes Across Diverse Populations (2005-2020)
• CISNET – Comparative Modelling: Informing Breast Cancer Control Practice Policy (2005-2020)
• Research-based evaluation of the Norwegian Breast Cancer Screening Program (Norway Research Council)
• Validation of the Erasmus MC MISCAN-Fadia model for cost-effectiveness analyses of mammography screening in Singapore (NMRC)
• Dutch-Belgian (NELSON-) RCT on lung cancer screening by low dose spiral CT in high-risk subjects (ZonMw, KWF Kankerbestrijding)
• MRI screening trial for women with a high risk of breast cancer and analysis of its cost-effectiveness (ZonMw, KWF Kankerbestrijding)
• Dutch nationwide breast cancer screening programme 1991-2017 (RIVM)
• Dutch nationwide cervical cancer screening programme 1991-2017 (RIVM)
• Dutch nationwide colorectal cancer screening programme 2014-2019 (RIVM)
• Health Technology Assessment for CT lung cancer screening including modelling of outcomes and cost-effectiveness (Sunnybrook Health Sciences, Toronto, Canada)
• SCOR Global Life. Forecast age specific incidences for DCIS (Carcinoma in situ of the breast) and invasive breast cancer for South Korea under the assumption of various screening scenarios
• HORIZON 2020 – ITN - A new era in personalised medicine: Radiomics as decision support tool for diagnostics and theragnostics in oncology (PREDICT) 2017
• NIH PO1 – Integrative analysis of lung cancer aetiology and risk 2017
• CISNET – Comparative Modelling of Colorectal Cancer: Informing Health Policies and Prioritizing Future Research (NIH/NCI, USA)
• CISNET - Comparative modelling to inform cervical cancer control policies (NIH/NCI, USA)
• European Randomised Study of Prostate cancer screening (ERSPC) (ZonMw, KWF Kankerbestrijding, Beckman, NCI)
• Screening of coeliac disease in the Preventive Youth Health Care Centres in the Netherlands (GLUTENSCREEN) (ZonMw) 2017
• DENSE Trial: MR Imaging as an Additional Screening Modality for the Detection of Breast Cancer in Women Aged 50-75 Years with Extremely Dense Breasts (ZonMw)
• PRISMA (TOP-subsidy): breast cancer screening – from one-size-fits-all to a personalized risk-based approach (ZonMw)
• Towards risk-stratified guidelines for surveillance and treatment of patients with Barrett's oesophagus (KWF Kankerbestrijding)
• Evaluating the long-term effectiveness and cost-effectiveness of population-based screening and treatment for prostate cancer: the CAP and ProtecT RCTs (Cancer Research UK)